FDA.reportPublic FDA data

OLANZapine 10 MG / samidorphan 10 MG Oral Tablet

RxCUI
2570399
RxNorm name
OLANZapine 10 MG / samidorphan 10 MG Oral Tablet
Display name
OLANZapine 10 MG / samidorphan 10 MG Oral Tablet
Full name
OLANZapine 10 MG / samidorphan 10 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LYBALVIOLANZAPINE AND SAMIDORPHAN L-MALATEAlkermes, Inc.32ffddd1-4e2b-45d9-9b36-bb730167ec802026-01-31Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2570399

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
32ffddd1-4e2b-45d9-9b36-bb730167ec80OLANZapine 10 MG / samidorphan 10 MG Oral Tablet [PSN] · olanzapine 10 MG / samidorphan 10 MG Oral Tablet [SCD] · olanzapine 10 MG / samidorphan 10 MG (as samidorphan L-malate 13.6 MG) Oral Tablet [SY]316These highlights do not include all the information needed to use LYBALVI ® safely and effectively. See full prescribing information for LYBALVI ® . LYBALVI ® (olanzapine and samidorphan) tablets, for oral use Initial U.S. Approval: 202120260131